Abstract Expression of the receptor tyrosine kinase HER3 is negatively correlated with survival in ovarian cancer, and HER3 overexpression is associated with cancer progression and therapeutic resistance. Thus, improvements in HER3-targeted therapy could lead to significant clinical impact for ovarian cancer patients. Previous work from our group established multivalency as a potential strategy to improve the therapeutic efficacy of HER3-targeted ligands, including affibodies....
Ιατρική : Τα αισθητικά συστήματα της όρασης,ακοής,αφής,γεύσης και όσφρησης.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Comparative gene expression profiling reveals key pathways and genes different in skin epidermal stem cells and corneal epithelial cells Abs...
-
Background: Tuberculosis is the second leading cause of death from an infectious disease worldwide after HIV, thus reasoning the expeditions...
-
Survival after radiotherapy versus radical cystectomy for primary muscle‐invasive bladder cancer: A Swedish nationwide population‐based coho...
-
Publication date: May 2017 Source: Neuroimaging Clinics of North America, Volume 27, Issue 2 http://ift.tt/2pfkGFe http://ift.tt/2...
-
AbstractBackground The 2014 Eighth Joint National Committee panel recommended a therapeutic target of systolic blood pressure (BP) <150 ...
-
Climatic variations within the dry valleys in southwestern China and the influences of artificial reservoirs Abstract Climatic variation wit...
-
Cells, Vol. 8, Pages 1372: Wnt-3a Induces Cytokine Release in Human Mast Cells Cells, Vol. 8, Pages... Cells, Vol. 8, Pages 1372: Wnt-3a Ind...
-
Barriers to dental care for children with special needs: General dentists' perception in Kerala, India : Amith Adyanthaya, Natta Sreelak...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου